Viewing StudyNCT02414139

Bugs

eRecord

Ignite Creation Date: 2024-05-06 @ 3:56 AM

Last Modification Date: 2024-10-26 @ 11:41 AM

Study NCT ID: NCT02414139

Status: COMPLETED

Last Update Posted: 2024-03-20

First Post: 2015-03-31

Brief Title: Study of Oral cMET Inhibitor INC280 in Patients With EGFR Wild-type wt Advanced Non-small Cell Lung Cancer NSCLC Geometry Mono-1

Sponsor: Novartis Pharmaceuticals

Organization: Novartis

Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions:

Name

Carcinoma Non-Small-Cell Lung

Keywords:

Name	View

Non Small Cell Lung	View
Non Small Cell Lung Cancer	View
Non-small cell lung cancer	View
NSCLC	View
INC280	View
EGFR wild-type wt	View
advanced non-small cell lung cancer	View
advancedmetastatic disease	View
Non-small cell lung carcinoma NSCLC	View
treatment of lung cancer after first metastasis	View
lung cancer	View
lung adenocarcinoma	View
Non small cell lung carcinoma	View
MET exon 14 deletion	View
METex14del	View
MET exon 14 skipping	View
MET exon 14 mutation	View
MET mutation	View
MET amplification	View
MET inhibitor	View
MET dysregulation	View
MET activation	View
MET signaling	View
MET pathway	View
met	View
cMET	View
Geometry mono-1	View
Geometry	View